Company Filing History:
Years Active: 2000-2008
Title: Andreas Busch: Innovator in Medical Research
Introduction
Andreas Busch is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of medical research, particularly in the area of treatments for aging processes and potassium channel proteins. With a total of 4 patents, his work has the potential to impact various therapeutic approaches.
Latest Patents
One of his latest patents is a method for identifying compounds that treat aging processes in the coronary circulatory system. This invention focuses on modifying the activity of the urotensin II receptor, influencing genes or gene products involved in the structure, formation, or breakdown of the extracellular matrix. Another significant patent involves a nucleic acid molecule encoding the potassium channel protein KCNQ5. This patent describes DNA encoding KCNQ5 or a polypeptide with KCNQ5 activity, along with related vectors, host cells, and methods for screening compounds that modify the activity of the potassium channel KCNQ5.
Career Highlights
Throughout his career, Andreas Busch has worked with various companies, including Tinnitus Forschungs- und Entwicklungs GmbH and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical research.
Collaborations
Andreas has collaborated with notable professionals in his field, including Hans Peter Zenner and J. Peter Ruppersberg. These collaborations have further enriched his research and contributed to his success as an inventor.
Conclusion
Andreas Busch is a distinguished inventor whose work in medical research has led to valuable patents and collaborations. His innovative approaches to treating aging processes and potassium channel proteins highlight his commitment to advancing healthcare solutions.